Surgery Partners, Inc. — Form 8-K
Filed October 26, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
Surgery Partners, Inc. agreed to be acquired by Spyglass Topco LLC (backed by Bon Secours Mercy Health) for $23.50 per share in an all-cash merger. The deal values the company at approximately $3.0B in equity value. Reinvestment stockholders (BCPE entities) will roll over certain shares. Company stockholders must approve; special committee oversight included.
Why this rating
Going-private transaction at material discount to trading range; eliminates public equity; changes ownership/control fundamentally. Highly significant relative to $2.6B market cap.
Tradability signal
NO TRADE
No trade: negative news, but this cell's evidence is too weak. Similar past filings (19 in this cell) moved +0.68% in the called direction over 4 hrs; shrunk for sample size that's a +0.29% edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $19.46 ▲ 23.56% | at our read · unknown $15.75 | +10 min · unknown $15.75 ▲ 0.00% | +30 min · unknown $23.02 ▲ 46.17% | +1 hr · unknown $23.03 ▲ 46.22% | +4 hrs pending |
The stock had already moved -19.06% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 26, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.